EDITORIAL
Published on 16 Jul 2024
Editorial: Liquid-biopsy-guided biomarker and drug discovery
doi 10.3389/fphar.2024.1454960
- 546 views
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Liquid-biopsy-guided biomarker and drug discovery
Liquid-biopsy-guided biomarker and drug discovery
3,999
Total downloads
12k
Total views and downloads
Articles
REVIEW
Published on 21 May 2024
Status of breast cancer detection in young women and potential of liquid biopsy
doi 10.3389/fonc.2024.1398196
- 1,504 views
- 1 citation
BRIEF RESEARCH REPORT
Published on 10 May 2024
Lysosomal degradation of PD-L1 is associated with immune-related adverse events during anti-PD-L1 immunotherapy in NSCLC patients
doi 10.3389/fphar.2024.1384733
- 1,501 views
- 3 citations
ORIGINAL RESEARCH
Published on 07 May 2024
Combination of plasma MMPs and PD-1-binding soluble PD-L1 predicts recurrence in gastric cancer and the efficacy of immune checkpoint inhibitors in non-small cell lung cancer
doi 10.3389/fphar.2024.1384731
- 1,650 views
- 2 citations
REVIEW
Published on 22 Apr 2024
Unveiling acquired resistance to anti-EGFR therapies in colorectal cancer: a long and winding road
doi 10.3389/fphar.2024.1398419
- 2,207 views
- 5 citations
ORIGINAL RESEARCH
Published on 13 Nov 2023
Natural killer cell-related prognosis signature predicts immune response in colon cancer patients
doi 10.3389/fphar.2023.1253169
- 1,603 views
- 4 citations
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore